These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 3087695

  • 1. Enhanced metabolism of levonorgestrel during phenytoin treatment in a woman with Norplant implants.
    Odlind V, Olsson SE.
    Contraception; 1986 Mar; 33(3):257-61. PubMed ID: 3087695
    [Abstract] [Full Text] [Related]

  • 2. Plasma levels of levonorgestrel and free levonorgestrel index in women using NORPLANT implants or two covered rods (NORPLANT-2).
    Olsson SE, Odlind V, Johansson ED, Nordström ML.
    Contraception; 1987 Mar; 35(3):215-28. PubMed ID: 3111784
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Contraception by Norplant subdermal capsules is not reliable in epileptic patients on anticonvulsant treatment.
    Haukkamaa M.
    Contraception; 1986 Jun; 33(6):559-65. PubMed ID: 3095023
    [Abstract] [Full Text] [Related]

  • 5. First week drug concentrations in women with levonorgestrel rod or Norplant capsule implants.
    Sivin I, Lähteenmäki P, Mishell DR, Alvarez F, Diaz S, Ranta S, Grozinger C, Lacarra M, Brache V, Pavez M, Nash H, Stern J.
    Contraception; 1997 Nov; 56(5):317-21. PubMed ID: 9437561
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sex hormone binding globulin and free levonorgestrel index in the first week after insertion of Norplant implants.
    Alvarez F, Brache V, Tejada AS, Cochon L, Faundes A.
    Contraception; 1998 Oct; 58(4):211-4. PubMed ID: 9866001
    [Abstract] [Full Text] [Related]

  • 9. Contraception with subdermal implants releasing levonorgestrel. A clinical and pharmacological study.
    Olsson SE.
    Acta Obstet Gynecol Scand Suppl; 1987 Oct; 142():1-45. PubMed ID: 3116821
    [Abstract] [Full Text] [Related]

  • 10. The interaction between sex hormone binding globulin and levonorgestrel released from Norplant, an implantable contraceptive.
    Affandi B, Cekan SZ, Boonkasemsanti W, Samil RS, Diczfalusy E.
    Contraception; 1987 Feb; 35(2):135-45. PubMed ID: 3109803
    [Abstract] [Full Text] [Related]

  • 11. Norplant: subdermal implant system for long-term contraception.
    Shoupe D, Mishell DR.
    Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1286-92. PubMed ID: 2497646
    [Abstract] [Full Text] [Related]

  • 12. Norplant implants: the mechanism of contraceptive action.
    Segal SJ, Alvarez-Sanchez F, Brache V, Faundes A, Vilja P, Tuohimaa P.
    Fertil Steril; 1991 Aug; 56(2):273-7. PubMed ID: 1906407
    [Abstract] [Full Text] [Related]

  • 13. Norplant-2 subdermal contraceptive system: experience in Taiwan.
    Lee TY, Yang YS, Tseng LH, Ko TM, Hsu MC, Chuang SM.
    J Formos Med Assoc; 1993 May; 92(5):446-50. PubMed ID: 8104598
    [Abstract] [Full Text] [Related]

  • 14. Androgen levels in women using Norplant implants.
    Olsson SE, Odlind V, Johansson E.
    Contraception; 1986 Aug; 34(2):157-67. PubMed ID: 2946553
    [Abstract] [Full Text] [Related]

  • 15. Abnormal endocrine profile among women with confirmed or presumed ovulation during long-term Norplant use.
    Alvarez F, Brache V, Tejada AS, Faúndes A.
    Contraception; 1986 Feb; 33(2):111-9. PubMed ID: 3084166
    [Abstract] [Full Text] [Related]

  • 16. Estradiol plasma levels during long-term treatment with Norplant subdermal implants.
    Croxatto HB, Díaz S, Pavez M, Brandeis A.
    Contraception; 1988 Oct; 38(4):465-75. PubMed ID: 3145171
    [Abstract] [Full Text] [Related]

  • 17. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
    Sivin I, Stern J, Diaz S, Pavéz M, Alvarez F, Brache V, Mishell DR, Lacarra M, McCarthy T, Holma P.
    Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
    [Abstract] [Full Text] [Related]

  • 18. Ovarian endocrine function through five years of continuous treatment with NORPLANT subdermal contraceptive implants.
    Brache V, Alvarez-Sanchez F, Faundes A, Tejada AS, Cochon L.
    Contraception; 1990 Feb; 41(2):169-77. PubMed ID: 2107058
    [Abstract] [Full Text] [Related]

  • 19. Plasma progesterone levels during long-term treatment with levonorgestrel silastic implants.
    Croxatto HB, Diaz S, Pavez M, Miranda P, Brandeis A.
    Acta Endocrinol (Copenh); 1982 Oct; 101(2):307-11. PubMed ID: 6814139
    [Abstract] [Full Text] [Related]

  • 20. The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study.
    Sivin I, Campodonico I, Kiriwat O, Holma P, Diaz S, Wan L, Biswas A, Viegas O, el din Abdalla K, Anant MP, Pavez M, Stern J.
    Hum Reprod; 1998 Dec; 13(12):3371-8. PubMed ID: 9886517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.